Please Wait

Applying Filters...

Looking for MabThera? Find Controlled & Modified Release used in MabThera to address drug delivery challenges on PharmaCompass.

MabThera

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

8 API Suppliers, 8 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

140 Drugs in Development

140 Drugs in Development

FINISHED DOSAGE FORMULATIONS

65 FDF Dossiers, 9 FDA Orange Book, 14 Europe, 7 Canada, 24 Australia, 9 South Africa, 2 Listed Dossiers

RELATED EXCIPIENT COMPANIES

1 Jai Radhe Sales, 1 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 6 Actylis, 1 BASF, 4 Gangwal Chemicals, 1 Nanjing Bold Chemical, 6 Seppic

EXCIPIENTS BY APPLICATIONS

10 Solubilizers, 8 Parenteral, 3 Emulsifying Agents, 3 Topical, 2 Thickeners and Stabilizers, 2 Controlled & Modified Release, 2 Film Formers & Plasticizers, 2 Surfactant & Foaming Agents, 1 Co-Processed Excipients, 1 Direct Compression, 1 Taste Masking, 1 Rheology Modifiers, 1 API Stability Enhancers

DIGITAL CONTENT

8 DATA COMPILATION #PharmaFlow, 1 STOCK RECAP #PipelineProspector, 222 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 11 Finished Drug Prices, 32 Annual Reports

MARKET PLACE

4 APIs, 20 FDF Dossiers

PATENTS & EXCLUSIVITIES

15 Health Canada Patents

15 Health Canada Patents

$ Xls

Filters

MabThera

Filters

FILTER :

filter Company Reset all filters

4 All

01 4Actylis

filter Capability Reset all filters

filter Country Reset all filters

01

Actylis

SODIUM CITRATE DIHYDRATE MULTI-COMPENDIAL

Medlab Asia & Asia Health

Not Confirmed

02

Actylis

SODIUM CITRATE DIHYDRATE USP-NF

Medlab Asia & Asia Health

Not Confirmed